Close Menu

Mr. Le Van Nha Phuong

Deputy General Director

  • Year of birth: 1980
  • Hometown: Dong Thap
  • Nationality: Vietnamese
  • Qualification: Doctor of Pharmacy in France

Following investments in a series of High-tech plants under EU-GMP standard, demands for intellectual and high-ranking personnel in the pharmaceutical industry have become expedient.

Attracting human resources was a significant success of the Company in the past year, with the highlight that Mr. Le Van Nha Phuong – Doctor of Pharmacy in France officially joined Imexpharm from early 2017 at the position of Deputy General Director in charge of the Hightech Betalactam Plant in Binh Duong and R&D.

Duties

  • Member of the Internal Audit and Risk Management Subcommittee; Member of Strategic Subcommittee;
  • Supervising and reporting the implementation of strategic objectives of Production Division, the implementation of GMP and Safet - Quality - Environment - Control Expenses in factories;
  • Managing the Betalactam High- technology factory in Binh Duong (IMP3) and the Dietary Supplement Factory;
  • Supervising the implementation of the R&D Strategies of the Company;
  • Perform other rights and duties in accordance with the law, the Company’s Charter and the Decision of the Board of Directors. 

Employment History

  • 10/2004 – 4/2005: R&D employee at Domesco Medical Import Export Joint Stock Company.
  • 4/2005 – 8/2006: Deputy Director of R&D Department at Domesco.
  • 8/2006 – 8/2008: Director of Department of Export – International Supplies and Cooperation at Domesco.
  • 8/2010 – 10/2011: Director of R&D Department at Domesco.
  • 10/2011 – 3/2014: Deputy General Director of Domesco.
  • 4/2014 – 12/2016: Director of the plant of AMPHARCO.
  • 01/2017: Deputy General Director of Imexpharm Corporation, in charge of the High-tech Betalactam Plant in Binh Duong and R&D Division across the Company.
  • 04/2018 - 2020: Member of Board of Directors, Deputy General Director of Imexpharm Corporation.
  • 2020 - present: Deputy General Director of Imexpharm Corporation.